| Menopause |
1 |
1 |
| Lipids Management |
0 |
0.9 |
| Cardiovascular Risk Management |
0 |
0.52 |
| Lipoproteins |
0 |
0.48 |
| Vagina |
0 |
0.48 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.43 |
| LDL Cholesterol |
0 |
0.43 |
| Metabolism |
0 |
0.99 |
| Triglycerides |
0 |
0.34 |
| Estrogen |
0 |
0.27 |
| Plasma |
0 |
0.27 |
| Pain Management |
0 |
0.21 |
| Blood |
0 |
0.2 |
| Pain |
0 |
0.2 |
| Quality of Life |
0 |
0.2 |
| Pregnancy |
0 |
0.15 |
| Bone |
0 |
0.14 |
| Psychosocial |
0 |
0.14 |
| Tissue |
0 |
0.14 |
| Hemoglobin A1c |
0 |
0.1 |
| Adverse Effects |
0 |
0.07 |
| Board Certification |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Contraception |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Florida |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Hemoglobin |
0 |
0.07 |
| Hemorrhage |
0 |
0.07 |
| Hysterectomy |
0 |
0.07 |
| Insulin Resistance |
0 |
0.07 |
| Liver |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Transdermal |
0 |
0.07 |